Global Health Data Exchange - Discover the World's Health Data

Nepal National Sero-Prevalence Survey for COVID-19 October 2020

Nav

General Info
Original or alternative title 
ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION
Geography 
Nepal (NPL)
Coverage type 
Country
Time period covered 
10/2020 - 10/2020
Data type
Summary 

A multistage cluster sampling method was used to select a representative sample of the population. The administrative wards were considered as clusters, and 30 were selected from each province. In each cluster, 200-250 households were expected to be included. Then fifteen households were randomly selected from each selected cluster (or the segment) for inclusion in the survey. One eligible member of the selected household who was residing in Nepal for at least four weeks prior to the survey date was enrolled by a random selection. The eligible age limit was defined as six months or older. The estimated sample size for this survey to obtain a precise estimate of national level Seroprevalence was 3,150. The samples were tested for COVID-19 total antibody presence using WHO-approved WANTAI SARS-CoV-2 antibody ELISA kits. This ELISA test detects both IgM and IgG antibodies for SARSCoV-2 virus.

Citation
Suggested citation 
Ministry of Health and Population (Nepal), National Public Health Laboratory (Nepal), World Health Organization (WHO), World Health Organization Regional Office for South-East Asia (SEARO). Nepal National Sero-Prevalence Survey for COVID-19 October 2020.